- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Chidamide+venetoclax
Total 749 results
-
Sellas Life Sciences GroupActive, not recruitingAcute Myeloid LeukemiaUnited States, Spain, France, Taiwan, India, Hungary, Poland, Germany, Serbia, Greece
-
Hoffmann-La RocheActive, not recruitingChronic Lymphocytic Leukemia (CLL)United States, Italy, Australia, Spain, France
-
AbbVieCelgeneTerminatedMultiple MyelomaUnited States, Spain, United Kingdom
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Not yet recruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; Astex Pharmaceuticals, Inc.RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Beijing Friendship HospitalRecruitingHemophagocytic LymphohistiocytosisChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
Shengjing HospitalNot yet recruiting
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Ruijin HospitalNot yet recruitingDiffuse Large B Cell Lymphoma
-
Emory UniversityNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Uma BorateRecruitingTherapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
Massachusetts General HospitalAbbVieRecruiting
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Neutrophilic Leukemia | Myeloid Neoplasm | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Myelodysplastic/Myeloproliferative... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Ruijin HospitalActive, not recruitingAngioimmunoblastic T-cell LymphomaChina
-
University of Cape TownRecruitingHIV Status | Tuberculous PericarditisSouth Africa
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
Kerry RogersActive, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....Not yet recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic/Myeloproliferative Neoplasm | Refractory Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
AbbVieGenentech, Inc.TerminatedAcute Myelogenous Leukemia | Myelogenous Leukemia | Treatment Naive AMLUnited States, Australia, France, Germany
-
Yanyan LiuRecruiting
-
Alice MimsNational Cancer Institute (NCI)Recruiting
-
Canadian Cancer Trials GroupAbbVie; Roche Pharma AG; Incyte CorporationRecruiting
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Spain, Belgium, United Kingdom, Germany, Australia, Hong Kong, Denmark, France, Japan, Canada, Italy, Austria, Sweden, Switzerland
-
CellCentric Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non Hodgkin Lymphoma | Peripheral T Cell Lymphoma | Haematological Malignancy | Higher-risk Myelodysplastic SyndromeUnited Kingdom, United States, France, Sweden, Spain
-
M.D. Anderson Cancer CenterLoxo Oncology, Inc.; The Leukemia and Lymphoma SocietyRecruiting
-
AbbVieRecruitingHematologic MalignanciesUnited States, Australia
-
Guangdong Association of Clinical TrialsChinese Thoracic Oncology GroupRecruitingCarcinoma, Non-Small-Cell LungChina
-
Sun Yat-sen UniversityUnknownPeripheral T-cell LymphomaChina
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndromes | Myeloproliferative Chronic Myelomonocytic LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingPrimary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS) | Aggressive B-cell Lymphoma With Secondary Involvement of the CNSUnited States
-
Boehringer IngelheimCompleted
-
AbbVieGenentech, Inc.WithdrawnNon-Hodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
German CLL Study GroupAbbVie; Hoffmann-La Roche; Swiss Group for Clinical Cancer Research; Stichting... and other collaboratorsCompletedChronic Lymphocytic LeukemiaIreland, Germany, Israel, Austria, Belgium, Denmark, Switzerland, Finland, Sweden, Netherlands
-
Institute of Hematology & Blood Diseases Hospital...RecruitingRelapse Acute Myeloid LeukemiaChina
-
Delta-Fly Pharma, Inc.RecruitingTrial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th SalvageLeukemia, Myeloid, AcuteUnited States